Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: BIOCYTOGEN-B(02315) the Revenue is 586.68 M (+44.24%);the EBIT is 207.79 M (+110.1%);the EPS is 0.364 (+90.55%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.59B44.24%
----
----
EBIT
0.21B110.10%
----
----
EPS
0.363990.55%
----
----
Revenue
ActualEstimateUnit: HKD
qf
EBIT
ActualEstimateUnit: HKD
qf
Net income
ActualEstimateUnit: HKD
qf
EPS
ActualEstimateUnit: HKD
qf